Longitudinal study to assess the quantitative use of fundus autofluorescence for monitoring disease progression in choroideremia
<strong>Background:</strong> Characterisation of preserved autofluorescence (PAF) area in choroideremia (CHM) and its validity for monitoring disease progression in clinical trials is of importance. <strong>Methods:</strong> Eighty patients with molecularly confirmed CHM wer...
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
MDPI
2021
|